{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:28:26Z","timestamp":1793600906284,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacc.2026.03.081","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:40:16Z","timestamp":1778701216000},"page":"1093-1103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-5521","authenticated-orcid":false,"given":"Alexander S.F.","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Cawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hattenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Oetjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jacc.2026.03.081_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/biom13030407","article-title":"Alterations in the plasma protein expression pattern in congenital analbuminemia-a systematic review","volume":"13","author":"Foster","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jacc.2026.03.081_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajhg.2021.11.021","article-title":"Rare coding variants in 35 genes associate with circulating lipid levels-a multi-ancestry analysis of 170,000 exomes","volume":"109","author":"Hindy","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2026.03.081_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jacl.2022.10.011","article-title":"Severe hypercholesterolemia in a patient with very low albumin and normal renal function","volume":"17","author":"Varughese","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacc.2026.03.081_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.amjmed.2004.06.039","article-title":"Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia","volume":"117","author":"Del Ben","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2026.03.081_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2018.11.005","article-title":"Severe hypercholesterolaemia in a paediatric patient with congenital analbuminaemia","volume":"29","author":"D\u2019Addato","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2026.03.081_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fgene.2019.00336","article-title":"Diagnosis, phenotype, and molecular genetics of congenital analbuminemia","volume":"10","author":"Minchiotti","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.jacc.2026.03.081_bib7","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1681\/ASN.2020111583","article-title":"Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the Kaiser Permanente Nephrotic Syndrome Study","volume":"32","author":"Go","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2026.03.081_bib8","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/01.CIR.0000042673.07632.76","article-title":"Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study","volume":"106","author":"Djouss\u00e9","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.03.081_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41598-023-27974-w","article-title":"The negative association between serum albumin levels and coronary heart disease risk in adults over 45 years old: a cross-sectional survey","volume":"13","author":"Hou","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2026.03.081_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/ATVBAHA.119.313681","article-title":"Plasma albumin and incident cardiovascular disease: Results from the CGPS and an updated meta-analysis: results from the CGPS and an updated meta-analysis","volume":"40","author":"Ronit","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ancard.2020.07.012","article-title":"Serum albumin and cardiovascular disease: state-of-the-art review","volume":"69","author":"Arques","year":"2020","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.jacc.2026.03.081_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/gim.2015.187","article-title":"The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research","volume":"18","author":"Carey","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2026.03.081_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2022.23897","article-title":"Association of supernumerary sex chromosome aneuploidies with venous thromboembolism","volume":"329","author":"Berry","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.03.081_bib14","article-title":"The All of Us Research Program: data quality, utility, and diversity","volume":"3","author":"Ramirez","year":"2022","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.jacc.2026.03.081_bib15","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.03.081_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.ATV.15.5.678","article-title":"Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor","volume":"15","author":"Nawrocki","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.03.081_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s42003-024-05874-7","article-title":"Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction","volume":"7","author":"Jung","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011446","article-title":"Probing the limits of cis-acting gene regulation using a model of allelic imbalance quantitative trait loci","volume":"21","author":"Seoighe","year":"2025","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jacc.2026.03.081_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad149","article-title":"Rye: genetic ancestry inference at biobank scale","volume":"51","author":"Conley","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacc.2026.03.081_bib21","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/ATVBAHA.120.315904","article-title":"Large-scale screening for monogenic and clinically defined familial hypercholesterolemia in Iceland","volume":"41","author":"Bj\u00f6rnsson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jacc.2026.03.081_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jacc.2026.03.081_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","article-title":"Rare variant contribution to human disease in 281,104 UK Biobank exomes","volume":"597","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2026.03.081_bib25","article-title":"Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes","volume":"2","author":"Karczewski","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.jacc.2026.03.081_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3961\/jpmph.2012.45.2.98","article-title":"The association between serum albumin levels and metabolic syndrome in a rural population of Korea","volume":"45","author":"Cho","year":"2012","journal-title":"J Prev Med Public Health"},{"key":"10.1016\/j.jacc.2026.03.081_bib27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJM198506133122404","article-title":"The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity","volume":"312","author":"Appel","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.03.081_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0021-9150(96)05905-9","article-title":"The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia","volume":"126","author":"Joven","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2026.03.081_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/01.ATV.17.7.1369","article-title":"Lipoprotein kinetics in patients with analbuminemia: evidence for the role of serum albumin in controlling lipoprotein metabolism","volume":"17","author":"Maugeais","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.16.3.441","article-title":"Increased cholesteryl ester transfer activity in plasma from analbuminemic patients","volume":"16","author":"Braschi","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2026.03.081_bib31","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1523-1755.1998.00204.x","article-title":"A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients","volume":"54","author":"Demant","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2026.03.081_bib32","first-page":"301","article-title":"The role and indications of albumin in advanced liver disease","volume":"82","author":"Zaccherini","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jacc.2026.03.081_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11901-020-00521-1","article-title":"Hemodynamic and systemic effects of albumin in patients with advanced liver disease","volume":"19","author":"Tufoni","year":"2020","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jacc.2026.03.081_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11938-001-0022-6","article-title":"Hyperlipidemia in chronic cholestatic liver disease","volume":"4","author":"Longo","year":"2001","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"3","key":"10.1016\/j.jacc.2026.03.081_bib35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/gast.2003.1240854","article-title":"Hypercholesterolemia in primary biliary cirrhosis: getting to the heart of the matter?","volume":"124","author":"Chauhan","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2026.03.081_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2026.03.081_bib37","first-page":"62","article-title":"Correlation between serum cholesterol and serum albumin level in childhood nephrotic syndrome","volume":"3","author":"Hossain","year":"2016","journal-title":"Urol Nephrol Open Access J"},{"key":"10.1016\/j.jacc.2026.03.081_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program","volume":"627","year":"2024","journal-title":"Nature"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726059875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726059875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:48:19Z","timestamp":1793598499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726059875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0735109726059875"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.03.081","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.03.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}